Outcomes in HIV-HCV co-infected genotype 1 patients treated with peginterferon alfa-2a (400) plus ribavirin (RBV) 1000/1200 mg/d: Predictions based on a generalized additive model (GAM)
HEPATOLOGY（2007）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要